In vivo evidence suggested that sialidase inhibitors may attenuate thrombocytopenia in ITP secondary to anti-GPIbα antibodies, while splenectomy, which reduces Fc-dependent phagocytosis of opsonised platelets, may be of little benefit for these patients [32]. Here, GP1BA is linked to autoimmune thrombocytopenic purpura.